Purchase Order 75F40120P00256
Award Date 5/28/20
Potential Completion Date 5/28/25
Potential Value $127K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract is for the renewal of software subscriptions for the LHASA KNOWLEDGE SUITE NEXUS, including the Derek Nexus, Meteor Nexus, and Sarah Nexus software platforms, provided by Lhasa LIMITED, a non-profit organization based in Leeds, United Kingdom. The $43,953.00 fixed-price purchase order was awarded on August 26, 2025 by the U.S. Environmental Protection Agency's (EPA) Office of Chemical Safety and Pollution Prevention. The software supports critical functions such as chemical...
- The Food and Drug Administration (FDA) awarded a $1,025,611 firm fixed price purchase order to Ntelx Inc., a Virginia-based company, for a perpetual software license, software maintenance, and support of the NTELX tools and associated modules. The contract has a period of performance through March 9, 2030. Ntelx Inc. is a prime contractor that has previously provided software licenses and maintenance/upgrade services to the Department of the Navy and the FDA. This award does not have a set-aside...
- The Food and Drug Administration awarded a definitive firm fixed-price contract to Relx Inc.'s LexisNexis division on February 29, 2024, with a ceiling value of $1.18M and an ultimate completion date of September 29, 2029. The contract provides web-based access to an aggregated database delivering public records, legal, regulatory, news, and medical information to support FDA operations and decision-making. The work will be performed in Washington, DC, and the contract was awarded without a...
- The Food and Drug Administration awarded a firm fixed-price purchase order to Certara UK LIMITED (doing business as Certara) on September 6, 2023, for SIMCYP software licenses with a ceiling value of $815,948. The contract will be performed in Great Britain, United Kingdom, and is scheduled for ultimate completion by September 20, 2028. No set-aside designation was applied to this award. Certara provides physiologically-based pharmacokinetic (PBPK) modeling software that simulates drug...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm-fixed price purchase order contract to Icon Clinical Research LLC, a foreign-owned for-profit organization, for the CDER SOFTWARE LICENSE RENEWAL FOR ICON NONMEM FY22. The contract, with a potential value of $10,900.00, provides software licenses and renewals for the NONMEM (Nonlinear Mixed Effects Modeling) software, which is used by FDA clinical pharmacology reviewers and pharmacometricians. This...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Certara UK Limited, doing business as Certara, a for-profit limited liability company, for SIMCYP software licenses and maintenance support. The $114,316.00 contract will allow the FDA's Office of Clinical Pharmacology Drug Reviewers to complete their review of investigational new drugs. Certara has previously provided this physiologically-based pharmacokinetic modeling software to the FDA and...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Elsevier B.V., doing business as North-Holland (Publishing), for a PharmacoKinetic and Metabolizing Enzyme Modules subscription. The contract has a potential value of $529,066.01 and a completion date of September 29, 2021. The contract provides the FDA Library with unlimited online access to Elsevier's databases, including drug safety and efficacy data, to support...
- The Food and Drug Administration (FDA) awarded a $8,020,452.98 firm fixed-price purchase order contract to Lorenz International LLC, a foreign-owned, for-profit organization, for the provision of their LORENZ ECTD (electronic common technical document) software. This contract, which does not have a set-aside designation, will support the FDA's regulatory review and submission processes through software licensing, maintenance, technical support, and training services. Lorenz International LLC has...
- The Department of Health and Human Services Food and Drug Administration awarded a $954,448.72 delivery order contract to Dnanexus, Inc., doing business as Dnanexus Inc., located in Mountain View, California. The contract period is from February 18, 2022 through February 21, 2023 and utilizes a firm fixed price contract type. Under the terms of the contract, Dnanexus Inc. will provide services to accept Real World Data through PrecisionFDA into the Food and Drug Administration's Intelligent...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to Accessagility LLC, a for-profit limited liability company based in Vienna, Virginia. The contract is for the provision of the DNASTAR/LASERGENE software suite, which is a comprehensive DNA and protein sequence analysis software package. The contract has a total ceiling value of $14,185.92 and an ultimate completion date of September 24, 2026. The contract was...
The U.S. Food and Drug Administration (FDA) awarded a $126,975 firm fixed price purchase order contract to Lhasa LIMITED, a non-profit organization based in the United Kingdom. The contract is for a full membership to the Lhasa Knowledge Suite Nexus, which includes software platforms such as Derek Nexus, Meteor Nexus, Vitic Nexus, Sarah Nexus, and Zeneth. The contract provides software maintenance, technical support, and four option year license subscription renewals. The contract was awarded on May 28, 2020 and has a completion date of May 28, 2025. The original solicitation was a competitive open market procurement with no set-aside designation.
Generated 7/1/25, 6:27 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Lhasa Knowledge Suite Nexus (Lhasa Membership, Derek, Meteor, Vitic, Sarah Nexus, and Zeneth, Unlimited number of PC’s) Brand Name or Equal Combined Synopsis/Solicitation | FDA-RFQ-20-1227081 | Department of Health and Human Services Food and Drug Administration | Solicitation 1/2 | 5/27/20, 2:41 AM | |
FDA-RFQ-20-1227081 Annual Maintenance of Lhasa Nexus (Derek, Meteor, and Sarah), Vitic, Zeneth, and Sarah Chromosome Damage Model Brand Name or Equal | FDA-RFQ-20-1227081 | Department of Health and Human Services Food and Drug Administration | Solicitation 2/2 | 4/29/25, 8:16 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Other Administrative Action | $1.4k | 5/13/25 | |
| P00006 | Exercise an Option | $25.1k | 4/16/24 | |
| P00005 | Exercise an Option | $25.1k | 4/20/23 | |
| P00004 | Other Administrative Action | $0 | 9/4/22 | |
| P00003 | Exercise an Option | $25.1k | 5/25/22 |